Market Stats
Global AI in oncology Market size and share is currently valued at USD 1.23 billion in 2023 and is anticipated to generate an estimated revenue of USD 16.72 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 33.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
The newly published research report titled AI in oncology Market Statastics offers a comprehensive assessment of the market. It presents and showcases a dynamic vision of the global market scenario in terms of market statistics, market size, and competitive situation. The report provides an assessment of all the major factors, including emerging trends, growth drivers, consumption, production volume, and CAGR value. In addition, profit margins, price, and attentive opinions have been included.
Both quantitative and qualitative research methodologies have been included to provide an in-depth market comprehension. The report includes an analysis of all the key segments and sub-segments in the market. Besides, AI in oncology market performance in various regions has been analyzed in the study. The research report serves as a valuable resource for businesses and stakeholders who want to assess the current market state and make critical decisions for business growth.
AI in oncology Market Report Scope
The report gives a complete picture of opportunities and demands that are beneficial for stakeholders in the market. It assesses the key market dynamics and growth factors to determine the market value and the growth rate. The study is based on growth probability, industry news, and market trends. In addition, a deep market analysis and competing scenario, along with a SWOT analysis of major market competitors, has been provided.
Key Market Dynamics
➡️ Market Drivers:
The research report offers vital information on all the major factors driving the AI in oncology market demand. It provides a thorough assessment of the emerging trends in the market. Also, the latest opportunities market participants can capitalize on have been studied. What’s more, major market news and the introduction of new rules and policies have been taken into consideration.
➡️ Market Restraints:
The research report highlights the factors that may hinder market growth in the coming years. It sheds light on regional conflicts and regulatory issues that can cause significant barriers to the market’s progress. By knowing the major market restraints, stakeholders can make more strategic and informed decisions.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/ai-in-oncology-market
✍ Key Market Players
The report includes a thorough competitive analysis to help businesses identify the direct or indirect competitors to their products or services in the market. In addition, it helps stakeholders to compare themselves against other market participants in terms of vision, mission, value, and core strengths. Porter’s Five Forces analysis has been included in the study to help stakeholders identify the AI in oncology market competitive forces. The report can give stakeholders an overall understanding of the market’s competitive environment, making it criticial for devising effective operating strategies.
Some of the players in the market are:
Azra AI
IBM
Siemens Healthcare GmbH
Intel Corporation
GE HealthCare
NVIDIA Corporation
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI
January 2023: Massive Bio announced plans to integrate AI into oncology by developing and launching a product focused on drug matching.
February 2023: M2Gen partnered with Zephyr AI to advance drug and target discovery for oncology treatments.
February 2023: Hackensack Meridian introduced an AI-based brain cancer treatment designed to support the Neosoma method for tracking, data collection, and analysis.
March 2023: Illumina launched Connected Insights, a software platform aimed at facilitating tertiary analysis in oncology. With potential expansion into rare diseases, the software streamlines reporting and interpretation across various assay types, improving workflow efficiency and saving time.
Regional Analysis
The research report tracks the market growth trajectory across various regions and sub-regions. A thorough assessment of the various market segments at the regional, national, and global levels has been provided. Additionally, other important market aspects such as market consumers, supply chain analysis, and raw materials have been included. What’s more, businesses and stakeholders can tap into vital market revenue projections and worldwide projections by going through the AI in oncology market research report.
Major regions and sub-regions covered in the study are:
▫️ North America (US, Canada)
▫️ Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, and Rest of Europe)
▫️ Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, and Rest of Asia Pacific)
▫️ Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
▫️ Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)
Conclusion
The AI in oncology market research report provides a precise analysis of a rapidly growing market. It includes information on data sources, research findings, and an appendix for an in-depth market assessment. In addition, the most recent market developments have been highlighted to help stakeholders devise effective operating strategies.
More Trending Latest Reports By Polaris Market Research:
Digital Transaction Management Market
Tumor-induced Osteomalacia Market
Customer Experience Business Process Outsourcing Market